{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:33:13Z","timestamp":1792114393645,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012680","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000}}],"reference-count":73,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012680.pub2","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T07:28:14Z","timestamp":1555054094000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Adjuvant therapy with antidepressants for the management of inflammatory bowel disease"],"prefix":"10.1002","author":[{"given":"Antonina","family":"Mikocka-Walus","sequence":"first","affiliation":[{"name":"Deakin University Geelong; School of Psychology; 221 Burwood Highway Burwood, VIC Victoria Australia 3025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L","family":"Prady","sequence":"additional","affiliation":[{"name":"University of York; Department of Health Sciences; Seebohm Rowntree Area 2 York UK YO10 5DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Pollok","sequence":"additional","affiliation":[{"name":"The University of Adelaide; Faculty of Health and Medical Sciences; North Terrace Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J","family":"Esterman","sequence":"additional","affiliation":[{"name":"University of South Australia; Division of Health Sciences; Adelaide Australia"},{"name":"James Cook University; Australian Institute of Tropical Health and Medicine; Cairns Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L","family":"Gordon","sequence":"additional","affiliation":[{"name":"University of South Australia; School of Pharmacy and Medical Sciences; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Knowles","sequence":"additional","affiliation":[{"name":"Swinburne University of Technology; Department of Psychological Sciences; ATC1041 Hawthorn campus Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M","family":"Andrews","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital; Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"182","key":"10.1002\/14651858.CD012680.pub2-BIB0001|cit1","first-page":"92","article-title":"Evaluation of the influence of tianeptine on the psychosomatic status of patients with ulcerative colitis in remission","volume":"31","author":"Chojnacki","year":"2011","journal-title":"Polski Merkuriusz Lekarski"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4103\/1735-1995.165969","article-title":"Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double-blind controlled study","volume":"20","author":"Daghaghzadeh","year":"2015","journal-title":"Journal of Research in Medical Sciences"},{"issue":"7","key":"10.1002\/14651858.CD012680.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/ibd.21846","article-title":"Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study","volume":"18","author":"Goodhand","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0004|cit4","first-page":"509","article-title":"Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo-controlled trial","volume":"11","author":"Mikocka-Walus","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MCG.0000000000000098","article-title":"Treatment of residual inflammatory bowel disease symptoms with low-dose tricyclic antidepressants: why not?","volume":"48","author":"Drossman","year":"2014","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012680.pub2-BIB0006|cit6","first-page":"49","article-title":"Positive attendant effects of Paroxetin in Colitis ulcerosa","volume":"25","author":"Eirund","year":"1998","journal-title":"Psychiatrische Praxis"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00054725-201112002-00054","article-title":"The efficacy of antidepressant medications in management of IBD patients with functional GI symptoms","volume":"17","author":"Iskandar","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.14309\/00000434-201210001-01763","article-title":"Tricyclic antidepressants in the management of IBD patients with functional GI symptoms","volume":"107","author":"Iskandar","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD012680.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCG.0000000000000049","article-title":"Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease","volume":"48","author":"Iskandar","year":"2014","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/ajg.2011.142","article-title":"Increased risks of developing anxiety and depression in young patients with Crohn's disease","volume":"106","author":"Loftus","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/SGA.0000000000000182","article-title":"Experience with and attitudes toward psychotherapy and antidepressants among patients with inflammatory bowel disease and functional gastrointestinal disorders","volume":"39","author":"Mikocka-Walus","year":"2016b","journal-title":"Gastroenterology Nursing"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0012|cit12","unstructured":"NCT00126373 A Trial of Wellbutrin for Crohn's Disease Clinicaltrials.gov\/show\/NCT00126373"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0013|cit13","unstructured":"NCT02162862 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Clinicaltrials.gov\/show\/NCT02162862"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/jpc.12516","article-title":"Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: A nationwide case control study in Finland","volume":"50","author":"Virta","year":"2014","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"10","key":"10.1002\/14651858.CD012680.pub2-BIB0015|cit15","first-page":"599","article-title":"Clinical observation of flupentixol and melitracen combined with mesalazine for treatment of ulcerative colitis patients with anxiety and depression","volume":"19","author":"Xie","year":"2014","journal-title":"Chinese Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0016|cit16","unstructured":"Yantaras O Kani HC Bicakci E Bez Y Banzragch M Senkal Z The effects of psychiatric treatment in patients with inflammatory bowel disease: a prospective study Journal of Crohn's and Colitis 2016 S314 S5"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0017|cit17","article-title":"Duloxetine","volume-title":"Australian Medicines Handbook","author":"Australian Medicines Handbook Pty","year":"2012"},{"issue":"9","key":"10.1002\/14651858.CD012680.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008012.pub3","article-title":"Psychological and pharmacological interventions for depression in patients with coronary artery disease","author":"Baumeister","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012680.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/dme.12452","article-title":"Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review","volume":"31","author":"Baumeister","year":"2014","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"382-92","DOI":"10.1002\/jrsm.1297","article-title":"Methods for evidence synthesis in the case of very few studies","volume":"9","author":"Bender","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-244X-12-227","article-title":"The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study)","volume":"12","author":"Bennebroek Evertsz","year":"2012","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012680.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/ajg.2010.140","article-title":"A prospective population-based study of triggers of symptomatic flares in IBD","volume":"105","author":"Bernstein","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD012680.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopsych.2005.04.030","article-title":"A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study","volume":"58","author":"Brown","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0024|cit24","unstructured":"Crohn's Colitis Australia About Crohn's and Colitis www.crohnsandcolitis.com.au\/about-crohns-colitis"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0025|cit25","unstructured":"Crohn's and Colitis Foundation of America About the Epidemiology of IBD www.ccfa.org\/resources\/epidemiology.html"},{"issue":"373","key":"10.1002\/14651858.CD012680.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"28","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0027|cit27","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"11","key":"10.1002\/14651858.CD012680.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0029|cit29","article-title":"Chapter 9: Analysing data and undertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Deeks","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"7109","key":"10.1002\/14651858.CD012680.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1572-0241.2007.01094.x","article-title":"The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients","volume":"102","author":"Feagan","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD012680.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ajg.2014.148","article-title":"Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD012680.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00054725-200608000-00005","article-title":"Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys","volume":"12","author":"Fuller-Thomson","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0035|cit35","volume-title":"Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression","author":"Gartlehner","year":"2007"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0036|cit36","volume-title":"Second-generation antidepressants in the pharmacologic treatment of adult depression: An update of the 2007 comparative effectiveness review","author":"Gartlehner","year":"2011"},{"issue":"8","key":"10.1002\/14651858.CD012680.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010710","article-title":"Antidepressants for depression during pregnancy","author":"Gordon","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2468-1253(16)30206-0","article-title":"Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis","volume":"2","author":"Gracie","year":"2017","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.108.141259","article-title":"Do desipramine [10,11-dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and fluoxetine [N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats?","volume":"327","author":"Guemei","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7650","key":"10.1002\/14651858.CD012680.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012680.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/00365521.2012.743584","article-title":"Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics","volume":"48","author":"Haapamaki","year":"2013","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"7414","key":"10.1002\/14651858.CD012680.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0043|cit43","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011"},{"issue":"12","key":"10.1002\/14651858.CD012680.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1097\/MIB.0b013e318296ae5a","article-title":"The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review","volume":"19","author":"Knowles","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"10.1002\/14651858.CD012680.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.mehy.2004.06.036","article-title":"Therapeutic value of antidepressants in asthma","volume":"64","author":"Krommydas","year":"2005","journal-title":"Medical Hypotheses"},{"issue":"6","key":"10.1002\/14651858.CD012680.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MIB.0000000000001059","article-title":"Antidepressants in inflammatory bowel disease: A systematic review","volume":"23","author":"Macer","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012680.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hup.191","article-title":"The immunoregulatory effects of antidepressants","volume":"16","author":"Maes","year":"2001","journal-title":"Human Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/156652408784533832","article-title":"The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence","volume":"8","author":"Maunder","year":"2008","journal-title":"Current Molecular Medicine"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1745-0179-2-24","article-title":"Antidepressants and inflammatory bowel disease: a systematic review","volume":"2","author":"Mikocka-Walus","year":"2006","journal-title":"Clinical Practice and Epidemiology in Mental Health"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-230X-7-38","article-title":"\"It doesn't do any harm, but patients feel better\": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease","volume":"7","author":"Mikocka-Walus","year":"2007","journal-title":"BMC Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD012680.pub2-BIB0052|cit52","first-page":"48","article-title":"Can antidepressants influence the course of inflammatory bowel disease (IBD)? The current state of research","volume":"5","author":"Mikocka-Walus","year":"2009","journal-title":"European Gastroenterology and Hepatology Review"},{"issue":"2","key":"10.1002\/14651858.CD012680.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpsychores.2011.06.006","article-title":"The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit","volume":"72","author":"Mikocka-Walus","year":"2012","journal-title":"Journal of Psychosomatic Research"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012680.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012680.pub2-BIB0056|cit56","first-page":"509","article-title":"Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomized placebo-controlled trial","volume":"11","author":"Mikocka-Walus","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD012680.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200101000-00015","article-title":"Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance","volume":"32","author":"Nigro","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.bp.105.011015","article-title":"Antidepressant therapy and C-reactive protein levels","volume":"188","author":"O'Brien","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0059|cit59","unstructured":"Royal College of Physicians National audit of inflammatory bowel disease (IBD) service provision www.rcplondon.ac.uk\/projects\/outputs\/ibd-audit-and-transparency-data"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0060|cit60","volume-title":"Rang & Dale's Pharmacology","author":"Ritter","year":"2015"},{"issue":"11","key":"10.1002\/14651858.CD012680.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1155\/2012\/984575","article-title":"Inflammatory bowel disease: a Canadian burden of illness review","volume":"26","author":"Rocchi","year":"2012","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD012680.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003460.pub3","article-title":"Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome","author":"Ruepert","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012680.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1399-5618.2009.00706.x","article-title":"The history of lithium therapy","volume":"11","author":"Shorter","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0064|cit64","unstructured":"Sterne JA Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0065|cit65","first-page":"353","article-title":"In vitro immunoregulatory effects of antidepressants in healthy volunteers","volume":"55","author":"Szuster-Ciesielska","year":"2003","journal-title":"Polish Journal of Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012680.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006913.pub2","article-title":"Psychological interventions for treatment of inflammatory bowel disease","author":"Timmer","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012680.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1440-1746.2010.06302.x","article-title":"Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change","volume":"25","author":"Langenberg","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012680.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.02.007","article-title":"Antidepressants attenuate increased susceptibility to colitis in a murine model of depression","volume":"130","author":"Varghese","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0069|cit69","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"issue":"8","key":"10.1002\/14651858.CD012680.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1572-0241.2008.01980.x","article-title":"The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders","volume":"103","author":"Walker","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012680.pub2-BIB0071|cit71","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M The Newcastle-Ottawa scale (NOS) for assessing the quality of non randomised studies in meta-analyses www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"3","key":"10.1002\/14651858.CD012680.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"The WHOQOL Group","year":"1998","journal-title":"Psychological Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012680.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7326\/0003-4819-132-9-200005020-00011","article-title":"A systematic review of newer pharmacotherapies for depression in adults: evidence report summary","volume":"132","author":"Williams","year":"2000","journal-title":"Annals of Internal Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012680.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:09:32Z","timestamp":1628550572000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012680.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012680.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]}}}